Hydroxychloroquine versus Azithromycin for Hospitalized Patients with COVID-19. Results of a Randomized, Active Comparator Trial-Reference-Cited by-同舟云学术

Hydroxychloroquine versus Azithromycin for Hospitalized Patients with COVID-19. Results of a Randomized, Active Comparator Trial

Published:2021-04 Issue:4 Volume:18 Page:590-597
ISSN:2329-6933
Container-title:Annals of the American Thoracic Society
language:en
Short-container-title:Annals ATS

Author:

Brown Samuel M.¹¹^ORCID,Peltan Ithan¹¹^ORCID,Kumar Naresh¹²,Leither Lindsay¹¹,Webb Brandon J.²³⁴^ORCID,Starr Nathan⁵⁶,Grissom Colin K.¹¹,Buckel Whitney R.⁷^ORCID,Srivastava Rajendu⁸⁹,Butler Allison M.¹,Groat Danielle¹,Haaland Benjamin¹⁰,Ying Jian¹⁰,Harris Estelle¹,Johnson Stacy⁶,Paine Robert¹,Greene Tom¹⁰,Smith Rilee,Armbruster Brent,Brown Katie,Aston Valerie,Merrill Mardee,Nelson Amanda,Grant Diana,Crook Bri,Maestas Heather,Anderson Jacki,Kodakandla Prathyusha,Weaver Lisa,Greer Jorden,Barrios Macy

Affiliation:

1. Pulmonary and Critical Care Medicine

2. Infectious Diseases, and

3. Infectious Diseases

4. Infectious Diseases, Stanford University, Stanford, California; and

5. Hospital Medicine, Intermountain Medical Center, Murray, Utah

6. Hospital Medicine

7. Pharmacy Services and

8. Pediatric Inpatient Medicine, and

9. Healthcare Delivery Institute, Intermountain Healthcare, Murray, Utah

10. Division of Biostatistics, Population Health Sciences, University of Utah, Salt Lake City, Utah

Publisher